Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma.

By Farhad Azimi, R. Scolyer, Pavlina Rumcheva, M. Moncrieff, R. Murali, S. McCarthy, R. Saw, John F. Thompson. Journal of Clinical Oncology, 2012

720 citations recorded by the source corpus.

Subfields: Immunology, Oncology

View Paper: https://www.semanticscholar.org/paper/584f787e6b7bd565977fcda2bcebcda26c094251

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

1. Christopher Sander
2. K. Flaherty
3. Charles M. Perou
4. N. Sharpless

In Oncology

1. John N. Weinstein
2. Christopher Sander
3. K. Flaherty
4. Nikolaus Schultz
5. Peter W. Laird
6. Charles M. Perou
7. Gad Getz
8. Giovanni Ciriello

Citations in the corpus

• Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy (2014, neutral): “000 CD4 < CD8 28 (56) 9 (32) 19 (68) 10 (36) 18 (64) CD20þ B cells (n 1⁄4 51) Absent 34 (67) 23 (68) 11 (32) 0.”
• Genomic Classification of Cutaneous Melanoma (2015, background): “Although tumor-infiltrating lymphocytes have been associated with favorable prognosis inprimarymelanoma (Azimi et al., 2012), such an association has not been investigated in regional disease.”